Whittier Trust Co. of Nevada Inc. Sells 44,200 Shares of SPDR S&P Biotech ETF $XBI

Whittier Trust Co. of Nevada Inc. lowered its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 26.5% in the second quarter, Holdings Channel.com reports. The fund owned 122,518 shares of the exchange traded fund’s stock after selling 44,200 shares during the period. Whittier Trust Co. of Nevada Inc.’s holdings in SPDR S&P Biotech ETF were worth $10,160,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently modified their holdings of XBI. JPMorgan Chase & Co. lifted its position in shares of SPDR S&P Biotech ETF by 625.1% in the 1st quarter. JPMorgan Chase & Co. now owns 10,369,706 shares of the exchange traded fund’s stock worth $840,983,000 after acquiring an additional 12,344,558 shares during the period. Goldman Sachs Group Inc. lifted its position in shares of SPDR S&P Biotech ETF by 33.0% during the 1st quarter. Goldman Sachs Group Inc. now owns 13,524,858 shares of the exchange traded fund’s stock worth $1,096,866,000 after buying an additional 3,353,029 shares during the period. Simplex Trading LLC lifted its position in shares of SPDR S&P Biotech ETF by 116.1% during the 1st quarter. Simplex Trading LLC now owns 241,039 shares of the exchange traded fund’s stock worth $19,548,000 after buying an additional 1,741,445 shares during the period. Migdal Insurance & Financial Holdings Ltd. bought a new position in shares of SPDR S&P Biotech ETF during the 1st quarter worth approximately $85,155,000. Finally, Harel Insurance Investments & Financial Services Ltd. bought a new position in shares of SPDR S&P Biotech ETF during the 1st quarter worth approximately $48,660,000.

SPDR S&P Biotech ETF Price Performance

SPDR S&P Biotech ETF stock opened at $110.17 on Tuesday. The company has a market capitalization of $6.84 billion, a PE ratio of 11.47 and a beta of 0.97. SPDR S&P Biotech ETF has a one year low of $66.66 and a one year high of $110.96. The business has a 50 day simple moving average of $96.56 and a 200 day simple moving average of $86.95.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.